User Satisfaction with the Combined Oral Contraceptive Drospirenone 3 mg/Ethinylestradiol 20 μg (Yasminelle®) in Clinical Practice: A Multi-Country, Questionnaire-Based Study

By Short Mary  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 153-159

Adis International

Access to resources Recommend Favorite

Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg: As an Oral Contraceptive

By Wagstaff Antona J.  

Drugs, Vol. 67, Iss. 16, 2007-01 ,pp. : 2473-2477

Adis International

Access to resources Recommend Favorite

Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen): A Review of Its Use in Contraception, Premenstrual Dysphoric Disorder and Moderate Acne Vulgaris

By Fenton Caroline   Wellington Keri   Moen Marit D.   Robinson Dean M.  

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1749-1765

Adis International

Access to resources Recommend Favorite

Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg as an Oral Contraceptive: A Viewpoint by Paula Bednarek

By Bednarek Paula  

Drugs, Vol. 67, Iss. 16, 2007-01 ,pp. : 2478-2479

Adis International

Access to resources Recommend Favorite

Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1 mg/Ethinylestradiol 35 μg in Healthy Subjects: An Open-Label, Single-Sequence, Single-Centre Study

By Spence Rebecca   Mandagere Arun   Walker Gennyne   Dufton Christopher   Boinpally Ramesh  

Clinical Drug Investigation, Vol. 30, Iss. 5, 2010-05 ,pp. : 313-324

Adis International

Access to resources Recommend Favorite